,

Hao Huang1, Jie Kong1, Xu He1

  • 1Department of Interventional Radiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Heliyon
|June 13, 2024
PubMed
概括

这项研究开发了一种名谱,用于预测内血管治疗后急性下肢缺血症 (ALLI) 患者的无截肢生存率 (AFS). 该工具准确地识别了有风险的患者,有助于治疗决策.